4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0000899243-23-002219
Director sold 22,489 shares at an average $293.15 ($6,592,686)
- Director acquired 22,489 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Levy Richard S Director | 2023-01-17 | Option exercise | +12,489 | $105.08 | $1,312,344 | 21,589 | D |
| Levy Richard S Director | 2023-01-17 | Option exercise | +10,000 | $100.45 | $1,004,500 | 31,589 | D |
| Levy Richard S Director | 2023-01-17 | Sale | −100 | $285.28 | $28,528 | 31,489 | D |
| Levy Richard S Director | 2023-01-17 | Sale | −400 | $287.08 | $114,832 | 31,089 | D |
| Levy Richard S Director | 2023-01-17 | Sale | −300 | $288.91 | $86,673 | 30,789 | D |
| Levy Richard S Director | 2023-01-17 | Sale | −1,600 | $290.36 | $464,576 | 29,189 | D |
| Levy Richard S Director | 2023-01-17 | Sale | −3,325 | $291.66 | $969,770 | 25,864 | D |
| Levy Richard S Director | 2023-01-17 | Sale | −5,227 | $292.68 | $1,529,838 | 20,637 | D |
| Levy Richard S Director | 2023-01-17 | Sale | −3,548 | $293.54 | $1,041,480 | 17,089 | D |
| Levy Richard S Director | 2023-01-17 | Sale | −5,164 | $294.68 | $1,521,728 | 11,925 | D |
| Levy Richard S Director | 2023-01-17 | Sale | −2,325 | $295.45 | $686,921 | 9,600 | D |
| Levy Richard S Director | 2023-01-17 | Sale | −500 | $296.68 | $148,340 | 9,100 | D |
| Derivatives | |||||||
| Levy Richard S Director | 2023-01-17 | Option exercise · Stock Option (Right to buy) | −12,489 | 0 | D | ||
| Levy Richard S Director | 2023-01-17 | Option exercise · Stock Option (Right to Buy) | −10,000 | 0 | D | ||
| Open-market sales · 22,489 sh · avg $293.15 · $6,592,686 | |||||||
Loading xslF345X03/doc4.xml…